Franklin Resources
DNLI icon

Franklin Resources’s Denali Therapeutics DNLI Stock Holding History

Franklin Resources’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
56,662
+7,930
+16% +$163K ﹤0.01% 2123
2026
Q1 		$936K Sell
48,732
-11,538
-19% -$230K ﹤0.01% 2210
2025
Q4 		$995K Sell
60,270
-4,364
-7% -$73.7K ﹤0.01% 2086
2025
Q3 		$938K Buy
64,634
+109
+0.2% +$1.57K ﹤0.01% 2137
2025
Q2 		$903K Sell
64,525
-18,723
-22% -$264K ﹤0.01% 2041
2025
Q1 		$1.13M Buy
83,248
+8,386
+11% +$161K ﹤0.01% 1909
2024
Q4 		$1.53M Sell
74,862
-5,179
-6% -$133K ﹤0.01% 1822
2024
Q3 		$2.15M Buy
80,041
+2,901
+4% +$71.9K ﹤0.01% 1719
2024
Q2 		$1.79M Buy
77,140
+26,545
+52% +$510K ﹤0.01% 1734
2024
Q1 		$1.04M Sell
50,595
-2,606
-5% -$49K ﹤0.01% 1939
2023
Q4 		$1.14M Sell
53,201
-6,150
-10% -$122K ﹤0.01% 1599
2023
Q3 		$1.22M Buy
+59,351
New +$1.51M ﹤0.01% 1543
2022
Q1 		– Sell
-8,246
Closed -$368K – 2461
2021
Q4 		$368K Buy
+8,246
New +$391K ﹤0.01% 2016
2021
Q1 		– Sell
-2,833
Closed -$238K – 1989
2020
Q4 		$238K Buy
+2,833
New +$171K ﹤0.01% 1687

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's DNLI Position: Q2 2026 in Review

Franklin Resources increased its Denali Therapeutics (DNLI) stake by 16% in Q2 2026, buying an estimated $163K and bringing the position to 56,662 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Franklin Resources first reported a position in DNLI in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.15M in Q3 2024. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Franklin Resources held 56,662 shares of Denali Therapeutics worth $1.46M as of Q2 2026.
  • Franklin Resources bought 7,930 Denali Therapeutics shares in Q2 2026, an estimated $163K.
  • Denali Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2123 holding.
  • Franklin Resources first reported a position in Denali Therapeutics in Q4 2020 and has held it in 14 quarters since.
  • Franklin Resources's Denali Therapeutics position peaked at $2.15M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.